As a transcriptional co-regulator, Nuclear protein 1 plays a key role in the endocrine therapy of breast cancer, thus representing a sensitive therapeutic target for the study of endocrine resistance of breast cancer [18]. The gene discussed is NUPR1; the disease is breast carcinoma.